Type 1 Diabetes and Kidney Disease: What New Research Reveals About Asian Populations
A major study tracking chronic kidney disease across Asia found that Type 1 diabetes plays a significant role in kidney-related deaths in Southeast Asia. Understanding these regional differences helps researchers identify where better prevention and care are needed most.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Type 1 diabetes contributed significantly to chronic kidney disease deaths in Southeast Asia, with a mortality rate of 3.18 per 100,000 people
- Southeast Asia carried the heaviest overall burden of chronic kidney disease in 2023, with higher death rates and disability impact than other Asian regions
- Chronic kidney disease patterns differ across Asian subregions, suggesting that one-size-fits-all approaches may not work for prevention and treatment
- High blood sugar levels (measured as fasting plasma glucose) were the leading risk factor for chronic kidney disease across most Asian regions
Why This Matters for the Type 1 Community
People with Type 1 diabetes face a higher risk of developing chronic kidney disease (CKD)—a condition where the kidneys gradually lose their ability to filter waste from the blood. A new large-scale study examining health data from 34 Asian countries between 1990 and 2023 shows just how important this connection is in certain regions.
Researchers analyzed millions of health records to understand the burden of chronic kidney disease across Asia, including how many people developed it, how many died from related complications, and which underlying causes mattered most in different areas. The findings highlight regional differences that have often been overlooked.
Type 1 Diabetes as a Driver of Kidney Disease in Southeast Asia
In Southeast Asia, Type 1 diabetes emerged as a significant contributor to chronic kidney disease deaths. The study found a mortality rate of 3.18 deaths per 100,000 population specifically linked to Type 1 diabetes causing kidney disease—a notably higher rate than in other Asian subregions.
This finding underscores the importance of good blood sugar management and regular kidney health monitoring for people with Type 1 diabetes, especially in Southeast Asian communities. While the research does not explain why Southeast Asia shows this pattern, it signals where public health efforts and clinical care systems may need to focus.
The Broader Picture: Chronic Kidney Disease Across Asia
Southeast Asia experienced the heaviest overall burden of chronic kidney disease in 2023, with the highest death rates and the most years of life lost to disability among all Asian subregions. The research also revealed that younger women—those under 35 years old—in South and Southeast Asia carried a higher disease burden than men in the same age groups, a pattern that researchers did not find in other regions.
Across most of Asia, high fasting blood glucose levels (a marker of diabetes and blood sugar control) were identified as the leading risk factor for chronic kidney disease. This connection between blood sugar control and kidney health applies to people with Type 1 diabetes, who must balance their insulin therapy with diet, exercise, and regular medical monitoring.
What This Research Tells Us
This study reveals that chronic kidney disease is not a uniform problem across Asia—different subregions face different challenges and risk factors. For the Type 1 diabetes community, the data highlights why kidney health is a central part of long-term care, particularly in Southeast Asia where the link between Type 1 diabetes and kidney disease appears especially strong.
While this research identifies patterns and risk factors, it does not offer new treatments or prevention strategies. Instead, it serves as a call for health systems to tailor their approaches to regional needs and for people living with Type 1 diabetes to work closely with their care teams on kidney disease screening and blood sugar management.
Evidence label
Source: Nephrology (Carlton, Vic.). Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Causes & What We KnowPregnant Women with Diabetes Show Higher Rates of Toxoplasma InfectionPubMed indexed literature
- Causes & What We KnowExploring Rare Breast Inflammation: What BRCA Mutations and Type 1 Diabetes May SharePubMed indexed literature
- Causes & What We KnowUnderstanding Type 1 Diabetes: A Shift Toward Early InterventionPubMed indexed literature
- Causes & What We KnowHow Nutrition, Metabolism, and Immunity Connect: What the Lectin Pathway Tells UsPubMed indexed literature
- Causes & What We KnowLiver Changes in Cystic Fibrosis: What a New Study FoundPubMed indexed literature
- Causes & What We KnowWhy Do Finland and Sardinia Have So Much Type 1 Diabetes? Genetics Offers a New CluePubMed indexed literature